Cambia means change.Cambia is an independent non-profit institute creating new technologies, tools and paradigms to promote change and enable innovation.
2008 News Items
Com Ciência No. 102, Brazil
October 5, 2008
Brazil's leading online science journal interviews Richard Jefferson for a special issue on synthetic biology
The Australian, Australia
September 24, 2008
CAMBIA and the Queensland University of Technology are collaborating in the cause of making the patent system easier to navigate across a range of areas ......
ABIC 2008, Ireland
August 25, 2008
Monty Says, USA
June 28, 2008
MySQL Founders Monty Widenius & David Axmark sponsor and support Patent Lens
Business Standard, India
May 28, 2008
The current head of CSIR, Samir Brahmachari... believes that open source is a promising route to drug discovery and has been espousing the cause at public forums.
The Washington Post, USA
May 13, 2008
"...both sides have oversimplified the pros and cons of biotech crop patents."
April 18, 2008
“In biology we need new clarity in what’s out there [in terms of patented research], what’s coming down the turnpike, and the new legal and cultural instruments to get past them,” says [CAMBIA's CEO] Jefferson
News by year
News - Greatest Hits!
Below is a selection of the media pieces that best reflect the nature of our work from a scientific, IT and intellectual property perspective.
The Freedom to Innovate: A Privilege or a
Editorial of The Plant Cell, May 2007
"...efforts to make the claims of patents ... more transparent and navigable, such as the Patent Lens ...should be supported by all."
Tech LawForum, December 14, 2006
"Transparency in patents is a good idea others are getting into in a big way, but there's still room for mutual improvement."
Patently Transparent (info)
Nature Biotechnology , May 2006
"The ability to interpret and filter intellectual property (IP) has never been more important...Cambia's Patent Lens is a giant leap in the right direction"
Open Source BioTech
Red Herring, April 11, 2006
"Patent transparency is the lifeblood of the new open source." In a feature edition, renowned IT mag Red Herring focuses on Cambia's role in pushing the boundaries of the biotech industry.
Navigating the Future(s) of Biotech Intellectual
Nature Biotechnology, March 8, 2006
What impact is open source having on the biotech IP system?
Open Source Biotech: Science as a Tool for Social
Genome Canada's Bulletin, July 1, 2005
"If you can't win the game, then change the rules. That could be the mantra of Cambia..."
Open-Source Practices for Biotechnology'
New York Times, February 10, 2005
A profile of BIOS including a discussion of the Nature publication.
Gene Transfer to Plants by Divers Species of Bacteria
Nature, February 10, 2005
Cambia researchers publish a groundbreaking study demonstrating the viability of non-Agrobacterium bacteria in plant gene transfer.
- Skip to main menu
- Or continue reading for footer links and information.